|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/12/22 Creative Medical Tech Holdin… Inc 10-Q 6/30/22 46:3.3M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 870K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
11: R1 Cover HTML 62K
12: R2 Condensed Consolidated Balance Sheets HTML 87K
13: R3 Condensed Consolidated Balance Sheets HTML 23K
(Parenthetical)
14: R4 Unaudited Condensed Consolidated Statements of HTML 100K
Operations
15: R5 Unaudited Condensed Consolidated Statements of HTML 96K
Cash Flows
16: R6 Unaudited Condensed Consolidated Statements of HTML 83K
Stockholders' Equity (Deficit)
17: R7 Organization and Summary of Significant Accounting HTML 43K
Policies
18: R8 Licensing Agreements HTML 38K
19: R9 Related Party Transactions HTML 23K
20: R10 Debt HTML 22K
21: R11 Derivative Liabilities HTML 19K
22: R12 Stockbased Compensation HTML 34K
23: R13 Stockholders Equity HTML 26K
24: R14 Subsequent Events HTML 17K
25: R15 Organization and Summary of Significant Accounting HTML 63K
Policies (Policies)
26: R16 Organization and Summary of Significant Accounting HTML 24K
Policies (Tables)
27: R17 Licensing Agreements (Tables) HTML 22K
28: R18 Stockbased Compensation (Tables) HTML 34K
29: R19 Stockholders Equity (Tables) HTML 18K
30: R20 Organization and Summary of Significant Accounting HTML 40K
Policies (Details)
31: R21 Organization and Summary of Significant Accounting HTML 21K
Policies (Details Narrative)
32: R22 Licensing Agreements (Details) HTML 27K
33: R23 Licensing Agreements (Details Narrative) HTML 89K
34: R24 Related Party Transactions (Details Narrative) HTML 60K
35: R25 Debt (Details Narrative) HTML 51K
36: R26 Derivative Liabilities (Details Narrative) HTML 50K
37: R27 Stockbased Compensation (Details) HTML 25K
38: R28 Stockbased Compensation (Details 1) HTML 43K
39: R29 Stockbased Compensation (Details Narrative) HTML 30K
40: R30 Stockholders Equity (Details) HTML 24K
41: R31 Stockholders Equity (Details Narrative) HTML 30K
44: XML IDEA XML File -- Filing Summary XML 74K
42: XML XBRL Instance -- celz_10q_htm XML 688K
43: EXCEL IDEA Workbook of Financial Reports XLSX 77K
8: EX-101.CAL XBRL Calculations -- celz-20220630_cal XML 100K
10: EX-101.DEF XBRL Definitions -- celz-20220630_def XML 293K
7: EX-101.LAB XBRL Labels -- celz-20220630_lab XML 604K
9: EX-101.PRE XBRL Presentations -- celz-20220630_pre XML 468K
6: EX-101.SCH XBRL Schema -- celz-20220630 XSD 133K
45: JSON XBRL Instance as JSON Data -- MetaLinks 239± 326K
46: ZIP XBRL Zipped Folder -- 0001477932-22-005931-xbrl Zip 161K
EXHIBIT 32.1
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with this Quarterly Report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Quarterly Report”), I, Timothy Warbington, Chief Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
|
| 1. | Such Quarterly Report on Form 10-Q for the period ended June 30, 2022, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| 2. | The information contained in such Quarterly Report on Form 10-Q for the period ended June 30, 2022 fairly presents, in all material respects, the financial condition and results of operations of Creative Medical Technology Holdings, Inc |
| Date: August 12, 2022 | By: |
| |
|
|
|
| |
|
|
| Chief Executive Officer |
|
|
|
| (Principal Executive Officer) |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/12/22 | None on these Dates | ||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/21 Creative Medical Tech Holdin… Inc 8-K:3,5,8,911/08/21 14:504K Discount Edgar/FA 11/05/21 Creative Medical Tech Holdin… Inc 8-K:3,5,9 11/02/21 15:1.5M Discount Edgar/FA 4/02/21 Creative Medical Tech Holdin… Inc 8-K:1,3,5,9 3/30/21 3:648K Discount Edgar/FA 3/17/21 Creative Medical Tech Holdin… Inc 10-K 12/31/20 60:8.3M Discount Edgar/FA 3/12/21 Creative Medical Tech Holdin… Inc 8-K:3,5,8,9 3/11/21 3:518K Discount Edgar/FA 1/16/18 Creative Medical Tech Holdin… Inc 8-K:1,5,9 1/12/18 2:47K Toppan Merrill/FA 11/18/08 Creative Medical Tech Holdin… Inc 10-12G 6:516K Action Edgar Fil… Svc/FA |